Trinity Biotech (TRIB) Gross Margin Growth (3y) (2012 - 2024)

Trinity Biotech (TRIB) Gross Margin Growth (3y) (2012 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 63.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 17.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 21.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 15.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -324.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 56.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 311.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -164.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Trinity Biotech 93,750.00 -5.04 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -632.00
Sep 30, 2024 -542.00
Jun 30, 2024 -648.00
Mar 31, 2024 -508.00
Dec 31, 2023 -1,377.00
Sep 30, 2023 -2,324.00
Jun 30, 2023 -669.00
Mar 31, 2023 -622.00
Dec 31, 2022 -932.00
Sep 30, 2022 -3,885.00
Jun 30, 2022 -575.00
Mar 31, 2022 -423.00
Dec 31, 2021 -466.00
Sep 30, 2021 -165.00
Jun 30, 2021 -56.00
Mar 31, 2021 -118.00
Dec 31, 2020 631.00
Sep 30, 2020 945.00
Jun 30, 2020 37.00
Mar 31, 2020 178.00